GALENA BIOPHARMA INC's ticker is GALE and the CUSIP is 363256504. A total of 51 filers reported holding GALENA BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $70,000 | – | 120,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 2,644,522 | $1,536,000 | 0.10% |
| ELEMENT CAPITAL MANAGEMENT LLC | 160,238 | $93,000 | 0.02% |
| DAFNA Capital Management LLC | 46,145 | $27,000 | 0.02% |
| Crescent Grove Advisors, LLC | 100,000 | $58,000 | 0.02% |
| EQUITEC SPECIALISTS, LLC | 174,500 | $101,000 | 0.02% |
| Virtu KCG Holdings LLC | 224,050 | $130,000 | 0.00% |
| LMR Partners LLP | 58,023 | $33,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 35,078 | $20,000 | 0.00% |
| Renaissance Technologies | 2,221,086 | $1,290,000 | 0.00% |
| EQUITEC SPECIALISTS, LLC | 22,500 | $13,000 | 0.00% |